Raniflax

Raniflax® (Ranitidine)

	General Description	–
	Side Effects	Headache, Abdominal pain, Agitation, Alopecia, Confusion, Constipation, Diarrhea, Dizziness, Hypersensitivity reaction, Nausea, Vomiting
	Direction of use	Adult:  Gastroesophageal Reflux Disease 150 mg PO q12hr  Gastric Ulcer, Benign Treatment: 150 mg PO q12hr or 300 mg PO at bedtime Maintenance of healing: 150 mg PO at bedtime Erosive Esophagitis Treatment: 150 mg PO q6hr Maintenance of healing: 150 mg PO q12hr Hypersecretory Conditions 150 mg PO q12hr; up to 6 g/day used Stress Ulcer Prophylaxis (Off-label) 150 mg PO or NG q12hr Pediatric: Active Duodenal/Gastric Ulcer Treatment: 4-8 mg/kg PO q12hr; not to exceed 300 mg/day Maintenance: 2-4 mg/kg PO once daily; not to exceed 150 mg/day  Gastroesophageal Reflux Disease 1 month – 16 years 5-10 mg/kg/day PO divided q12hr; not to exceed 300 mg/day  Erosive Esophagitis 1 month – 16 years 5-10 mg/kg/day PO divided q12hr; not to exceed 300 mg/day  Neonates (Off-label) Term Neonates (<29 days) 2-4 mg/kg/day PO divided q8-12hr
	Warnings	Hypersensitivity to ranitidine or components of the formulation
	Catalog	Raniflax® (Ranitidine) Catalog